Ionizing radiation and organic solvents such as benzene and other petroleum products have been associated with a higher risk of developing AML. Both ras mutations and polymorphisms resulting in the inactivation of nicotinamide adenine dinucleotide phosphate (NADPH) and reduced NADPH-quinone oxidoreductase have been found in patients with these exposures.